The introduction of nicotinamide as a nicotine alternative in e-cigarette and smokeless solutions signifies a substantial regulatory obstacle for that FDA. Nicotinamide does not have nicotinic receptor agonist action and is known to work as a sedative at large dosages6. The claims produced by Nicotine River, ECBlend, and other suppliers that their